ReviewBlood neoplasia2025

Safety landscape of bispecific antibody therapy in non-Hodgkin lymphoma: a meta-analysis.

Rodrigo Fonseca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.